作者: Richard S. Beard , Jason J. Reynolds , Shawn E. Bearden
DOI: 10.1182/BLOOD-2011-02-338269
关键词: Tight junction 、 Internal medicine 、 Receptor 、 Agonist 、 Memantine 、 Endothelium 、 Adherens junction 、 Blood–brain barrier 、 Endocrinology 、 Biology 、 NMDA receptor 、 Immunology
摘要: Hyperhomocysteinemia (HHcy) increases permeability of the blood-brain barrier, but mechanisms are undetermined. Homocysteine (Hcy) is an agonist neuronal N-methyl-D-aspartate receptor (NMDAr). We tested hypothesis that HHcy disrupts barrier by NMDAr-dependent mechanism in endothelium. In brain microvascular endothelial cells, there was no change expression adherens junction protein VE-cadherin with Hcy treatment, a significant decrease amount β-catenin at membrane. Moreover, caused nuclear translocation and attachment to promoter for tight claudin-5, concomitant reduction claudin-5 expression. Using murine model (cbs+/−), treatment 2 weeks NMDAr antagonist (memantine) rescued cerebrovascular both exogenous sodium fluorescein endogenous IgG. Memantine had effect on these parameters wild-type littermates. The same results were obtained using vitro cells. These data provide first evidence required Hcy-mediated permeability. Modulating cerebral activity may present novel therapeutic target diseases associated opening HHcy, such as stroke dementia.